Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of hematology Ročník 113; číslo 3; s. 330 - 336
Hlavní autoři:	Iba, Toshiaki, Connors, Jean Marie, Spyropoulos, Alex C., Wada, Hideo, Levy, Jerrold H.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Singapore Springer Singapore 01.03.2021 Springer Nature B.V
Témata:	Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Biological Variation, Population Bleeding Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology COVID-19 - virology Cultural differences Disease Management Disease Susceptibility Ethnicity Hematology Heparin Humans Medicine Medicine & Public Health Minority & ethnic groups Morbidity Mortality Oncology Post-Exposure Prophylaxis Prognosis Review Review Article SARS-CoV-2 Thromboembolism Thromboembolism - diagnosis Thromboembolism - epidemiology Thromboembolism - etiology Thromboembolism - prevention & control Thrombosis Venous Thromboembolism - etiology Venous Thromboembolism - prevention & control Viral diseases COVID-19 Ethnic difference Deep vein thrombus Thromboprophylaxis Thromboembolism
ISSN:	0925-5710, 1865-3774, 1865-3774
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!